EFFECTS OF ISO AND XENO FETAL LIVER FRAGMENTS TRANSPLANTATION ON ACUTE AND CHRONIC LIVER-FAILURE IN RATS

被引:15
作者
HAGIHARA, M
SHIMURA, T
TAKEBE, K
MUNKHBAT, B
TSUJI, K
机构
[1] Department of Transplantation Immunology, Tokai, University School of Medicine, Isehara, Kanagawa, 259-11, Bohseidai
关键词
FETAL LIVER; ACUTE LIVER FAILURE; CHRONIC LIVER FAILURE; OMENTUM;
D O I
10.1177/096368979400300404
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Isogeneic (rat) and xenogeneic (swine) fetal liver fragments (FLF) transplantation into the omentum was performed for D-galactosamine (D-Gal)-induced acute and carbon tetrachloride (CCl4)-induced chronic hepatic failure in rats. The recipients that had iso or xeno FLF showed higher survival rates than the nontransplanted controls on a lethal dose (2.6 g/kg body weight) of D-Gal (survival rates: Iso 70%, Xeno 80%, and control 9.1%). On a sublethal dose (1.0 or 1.2 g/kg) of D-Gal, iso, or xeno FLF caused marked improvement of the values of GPT, GOT, and total bilirubin (T.Bil); at 72 h after D-Gal injection they went significantly lower than those of controls (Iso vs. control; p < 0.01, Xeno vs. control; p < 0.05). Histological examination of the livers revealed severe damage in controls, however, only a slight damage was found in iso or xeno FLF transplanted rats. Iso grafts were fairly well preserved in the omentum at 72 h posttransplants, however, xeno graft had almost changed into a necrotic tissue. CCl4 was administered subcutaneously for 14 wk to induce chronic hepatic failure and then iso FLF were transplanted 3 days after the last CCl4 injection. Iso FLF transplanted rats showed higher improvement of GPT and GOT values at 12 days posttransplants compared with controls (GPT p < 0.01, GOT p < 0.05), although histological improvement was not so remarkable in both group. Iso grafts formed nodules with many hepatocytes in the omentum 12 days posttransplant. The results indicate that iso or xeno FLF transplantation could be an alternative approach for incurable liver insufficiencies.
引用
收藏
页码:283 / 290
页数:8
相关论文
共 23 条
[1]   THE EFFECT OF HEPATIC STIMULATORY SUBSTANCE, ISOLATED FROM REGENERATING HEPATIC CYTOSOL, AND 50,000 AND 300,000 SUBFRACTIONS IN ENHANCING SURVIVAL IN EXPERIMENTAL ACUTE HEPATIC-FAILURE IN RATS TREATED WITH D-GALACTOSAMINE [J].
FRANCAVILLA, A ;
DILEO, A ;
POLIMENO, L ;
GAVALER, J ;
PELLICCI, R ;
TODO, S ;
KAM, I ;
PRELICH, J ;
MAKOWKA, L ;
STARZL, TE .
HEPATOLOGY, 1986, 6 (06) :1346-1351
[2]   TRANSPLANTATION OF CRYOPRESERVED HEPATOCYTES OR LIVER CYTOSOL INJECTION IN THE TREATMENT OF ACUTE LIVER-FAILURE IN RATS [J].
GRUNDMANN, R ;
KOEBE, HG ;
WATERS, W .
RESEARCH IN EXPERIMENTAL MEDICINE, 1986, 186 (02) :141-149
[3]   HUMAN HEPATIC STIMULATOR SUBSTANCE - A PRODUCT OF GENE-EXPRESSION OF HUMAN FETAL LIVER-TISSUE [J].
HE, FH ;
WU, CS ;
TU, Q ;
XING, GC .
HEPATOLOGY, 1993, 17 (02) :225-229
[4]   DIRECT EVIDENCE THAT HEPATOCYTE GROWTH-FACTOR IS A HEPATOTROPHIC FACTOR FOR LIVER-REGENERATION AND HAS A POTENT ANTIHEPATITIS EFFECT INVIVO [J].
ISHIKI, Y ;
OHNISHI, H ;
MUTO, Y ;
MATSUMOTO, K ;
NAKAMURA, T .
HEPATOLOGY, 1992, 16 (05) :1227-1235
[5]  
LABRECQUE DR, 1982, AM J PHYSIOL, V242, pG289, DOI 10.1152/ajpgi.1982.242.3.G289
[6]   STIMULATION OF HTC HEPATOMA-CELL GROWTH-INVITRO BY HEPATIC STIMULATOR SUBSTANCE (HSS) - INTERACTIONS WITH SERUM, INSULIN, GLUCAGON, EPIDERMAL GROWTH-FACTOR AND PLATELET DERIVED GROWTH-FACTOR [J].
LABRECQUE, DR ;
WILSON, M ;
FOGERTY, S .
EXPERIMENTAL CELL RESEARCH, 1984, 150 (02) :419-429
[7]  
MAKOWKA L, 1981, TRANSPLANT P, V13, P855
[8]  
MAKOWKA L, 1980, SURGERY, V88, P244
[9]  
Mao-Hua Mei, 1993, Hepatology, V17, P638, DOI 10.1002/hep.1840170418
[10]  
MARTIN J, 1987, TRANSPLANT P, V19, P3930